Navigation Links
MedImmune Further Expands Autoimmune Disease Research Program Through Collaboration with SBI Biotech
Date:9/11/2008

GAITHERSBURG, Md. and TOKYO, Sept. 11 /PRNewswire/ -- MedImmune, the global biologics unit of AstraZeneca, and SBI Biotech Co., Ltd, a subsidiary of SBI Holdings, Inc., announced today that they have entered into a licensing and collaboration agreement to develop and commercialize SBI Biotech's anti-ILT7 protein for the potential treatment of systemic lupus erythematosus (SLE) and other autoimmune diseases. MedImmune has global rights to any resulting product candidates and will be responsible for preclinical and clinical development, as well as all future development, manufacturing, sales and marketing activities.

"It's an honor to work with Ken-ichi Arai, founder of SBI Biotech and one of Japan's leading scientists. We look forward to collaborating with him and his organization as we develop potential new treatments for autoimmune diseases such as SLE," said Anthony J. Coyle, Ph.D., vice president, research, respiratory, inflammation and autoimmunity. "As an innovative company dedicated to making a difference for patients, MedImmune will continue to seek out research and development initiatives that may address some of society's critical unmet medical needs."

Under the terms of the agreement, MedImmune is to provide SBI Biotech with an undisclosed upfront payment, milestone payments and royalties on future marketed products. SBI Biotech has granted MedImmune an exclusive license to research, develop and commercialize products that target the ILT7 protein. In addition, MedImmune will have the option to license additional targets resulting from SBI Biotech's research activities.

"We are pleased to collaborate with MedImmune, a company with strong capabilities to develop therapeutic antibodies including expertise in humanization and large-scale production. MedImmune is an excellent company and this agreement facilitates the research and development of an anti-ILT7 antibody," said Ken-ichi Arai, M.D. and Ph.D., president & CEO, SBI Biotech.
'/>"/>

SOURCE MedImmune
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. MedImmune Prepared to Support Implementation of Expanded ACIP Recommendations for Influenza Vaccinations
2. MedImmune Expands Scientific and Engineering Leadership
3. Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkins Lymphoma Patients
4. MedImmune presents new pharmaco-economic data at AAP regarding infants at high risk for RSV
5. MedImmune to present RSV surveillance and cost-effectiveness data at American Academy of Pediatrics
6. Medimmune announces phase 2 safety data for anti-RSV antibody and national RSV surveillance results
7. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
8. MedImmune Resolves FDA Observations Regarding Manufacturing Process for FluMist(R)
9. Further Acquisition for Schofield Media Group LLC
10. FTC Acts to Prevent Tobacco Industry Deception About Tar, Nicotine Levels; Congress Should Go Further by Giving FDA Authority Over Tobacco Products
11. Area Women Gather in Milford on July 10 to Further the Mission of Womens Caring Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2015)... National Sales Solutions , ... and supply chain management for consumer packaged goods ... its award winning solutions for thinning-damaged hair to ... specifically created to combat thinning-damaged hair. Known ... to marrying science with nature to create the ...
(Date:2/28/2015)... 28, 2015 A case management conference ... that have been filed by law firms including Bernstein ... in March, the Firm notes. , According to ... in the federal litigation will meet on March 13, ... prescription therapy treatments designed to raise levels of the ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 On Thursday, February ... Make It Easy For Scammers To Steal Your Data , ... get their hands on a DIY phishing kit, or any ... also touched on another important point about how everyone’s cyber ... are often implemented, “like compromising legitimate content management systems or ...
(Date:2/28/2015)... 2015 Developers of FCPX plugins ... overlay plugin for Final Cut Pro X entitled FCPX Overlay ... Chromatic gives users total control over 6k lens dirt overlays ... Pixel Film Studios. “FCPX Overlay Chromatic was professionally designed to ... interface.” , FCPX Overlay Chromatic Grunge 6K is a resourceful ...
(Date:2/28/2015)... Aliso Viejo, California (PRWEB) February 28, 2015 ... the release of TransFold Volume 2. A fully customizable ... Pro X. , “TransFold Volume 2 gives users total ... users,” said Christina Austin, CEO of Pixel Film Studios. ... Cut Pro X editor.” , TransFold Volume 2 from ...
Breaking Medicine News(10 mins):Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 3Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 2Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 3Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 4Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 3Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 4Health News:Pixel Film Studios released a new overlay plugin entitled FCPX Overlay Chromatic Grunge 6K exclusively for Final Cut Pro X users 2Health News:Announcing a New TransFold Transition Pack from Pixel Film Studios for Final Cut Pro X Professionals 2
... take place on March 10 in Los Angeles, ... Feb. 8 U.S. Health Disparities,Forum organizer Luis ... on Feb. 12 at 1 p.m. EST to ... and presenters will discuss new opportunities for,preventive care ...
... MBF Healthcare,Acquisition Corp. (AMEX: MBH ), a ... it will host an investor,conference call on Friday, ... to,discuss the recently announced signing of a definitive ... (along with its,subsidiaries, "CHS"). Hosting the call from ...
... Improved ... Quality of Sleep ... (TSX: DDS;,NASDAQ: DDSS) today announced that its recently completed North ... trazodone (study 04ACL3-001) achieved statistical,significance for the primary efficacy endpoint ...
... Offering Period, BASEL, Switzerland, Feb. 8 ... its wholly-owned,subsidiary Rocket Acquisition Corporation has accepted for ... offer for all outstanding,shares of common stock of ... at,$89.50 per share in cash., As of ...
... health and ... fitness cruise, RANCHO SANTA MARGARITA, Calif., Feb. 7 ... a 5-day Adventure Boot,Camp Fitness Cruise to the Mexican Riviera porting April 28, ... well as those experiencing the boot camp for the first time., Attendees ...
... research showed it greatly boosted pregnancy chances , , THURSDAY, ... fertilization can increase their chances of becoming pregnant by ... a preliminary study suggests. , , About 10 percent ... many opt for in vitro fertilization, in which a ...
Cached Medicine News:Health News:U.S. Health Disparities Forum to Hold Media Briefing 2Health News:MBF Healthcare Acquisition Corp. to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings, Inc. 2Health News:MBF Healthcare Acquisition Corp. to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings, Inc. 3Health News:MBF Healthcare Acquisition Corp. to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings, Inc. 4Health News:Labopharm Reports Positive Results for Phase III Study on Once-daily Trazodone 2Health News:Labopharm Reports Positive Results for Phase III Study on Once-daily Trazodone 3Health News:Roche Purchases Shares in Tender Offer for Ventana 2Health News:Roche Purchases Shares in Tender Offer for Ventana 3Health News:Roche Purchases Shares in Tender Offer for Ventana 4Health News:QueensLander Tours Presents an Adventure Boot Camp Cruise with John Spencer Ellis from Bravo's The Real Housewives of Orange County 2Health News:Acupuncture May Aid In Vitro Fertilization 2Health News:Acupuncture May Aid In Vitro Fertilization 3
(Date:2/27/2015)... 27, 2015  Organovo Holdings, Inc. (NYSE MKT: ... delivering breakthrough 3D bioprinting technology, announced today that ... Officer, will present live at VirtualInvestorConferences.com on March ... join us for this Company update," said Mr. ... commercial launch of the exVive3D Liver, Bioprinted Human ...
(Date:2/27/2015)... , Feb. 27, 2015  Two ... increasing in applications as their effectiveness is ... Kalorama Information.  Kalorama Information says that while ... the most powerful tool in proteomic biomarker ... MS) through its traditional techniques has struggled ...
(Date:2/26/2015)... 2015  Today the National Safety Council ... physical side effects of pain medications , ... Vicodin and Oxycontin, are safer options than over-the-counter pain ... painkillers than on heroin and cocaine combined," said ... "Yet, these medications are marketed as the Cadillac option ...
Breaking Medicine Technology:Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 2Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 3Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 4Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 3National Safety Council: Opioid prescription painkillers have hidden, deadly side effects 2
... 24, 2011 The National Community Pharmacists ... and Consumer Choice Act of 2011 , which ... pharmacy of their choice, eliminate needless pharmaceutical spending ... pharmacy audits. (Logo: http://photos.prnewswire.com/prnh/20100106/DC33253LOGO ) ...
... Technologies, Inc . ( http://mindtechnologiesinc.com ) (Pink Sheets: ... The Company,s proprietary EEG/ BCI headset, which is currently ... world leader in EEG/ BCI technology, Mind Technologies assembled ... of developing a state-of-the-art headset that would revolutionize the ...
Cached Medicine Technology:Community Pharmacists Endorse Bipartisan Pharmacy Competition and Consumer Choice Act 2Community Pharmacists Endorse Bipartisan Pharmacy Competition and Consumer Choice Act 3Mind Technologies Inc. Developing Revolutionary EEG Brain Computer Interface 2
Rapid test for the presumptive identification of Candida albicans from culture media....
... Virion\Serions comprehensive line of ELISA Classic serology ... viral, and fungal pathogens with rapid, standardized ... IgA antibodies. All of the ELISA antigens ... in their own laboratories under the control ...
Rapid reagent impregnated disk test for presumptive identification of Candida albicans....
Immunodiffusion tests are used for the detecion of precipitating antibodies (primarily of the IgG and IgA classes) against antigens of C. albicans. The presence of precipitating antibodies indicates ...
Medicine Products: